Review article · 9 Aug 2024
Conference abstractPublished 2015
When beta therapy fails – Is alpha therapy a solution? Actinium-225 production and applications
Brookhaven National Lab Upton USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A ctinium-225 ( 225 Ac) has a half life of 9.92 days, decaying through multiple intermediate nuclei to a daughter isotope Bismuth-213 ( 213 Bi) with a half life of 45 min. Both isotopes have been investigated for targeted alpha therapy. Researchers have shown 213 Bi DOTATOC can shrink tumors in patients that had previously not responded to similar treatments with the beta emitting isotopes 90 Y and 177 Lu. The United States Department of Energy (US DOE) supplies purified 225 Ac from a generator system associated with the parent isotope 229 Th, but this approach does not supply enough 225 Ac for the applications associated with both 225 Ac and 213 Bi. To meet this demand the US DOE has initiated a Tri-lab (Los Alamos-Brookhaven-Oak Ridge National Laboratories) effort to develop 225 Ac by irradiation of a thorium target with high energy (90-200 MeV) protons. One of the main challenges associated with this production route is isolation of 225 Ac from bulk thorium and other radionuclides (~400) formed as a result of fission and other nuclear reactions. In targeted alpha therapy with 225 Ac the retention of the multiple daughters of 225 Ac at the target site has been problematic. A chemical method to produce a targeting nanochelator to: capture 225 Ac, retain the daughters of alpha decay, and target tumors will be discussed
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Diagnostic Techniques and Biomedical Analysis.
Opinion · 29 Dec 2023
Molecular Diagnostics: Decoding Disease at the Genetic Level
Opinion · 29 Dec 2023
From Data Streams to Diagnoses: AI's Journey in Healthcare
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Diagnostic Techniques and Biomedical Analysis
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Jonathan Fitzsimmons”
